SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-12-018870
Filing Date
2012-03-19
Accepted
2012-03-19 10:45:52
Documents
1
Period of Report
2012-03-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 13488
  Complete submission text file 0001209191-12-018870.txt   14781
Mailing Address 25 UPTON DRIVE WILMINGTON MA 01887
Business Address 25 UPTON DRIVE WILMINGTON MA 01887 9786577500
DUSA PHARMACEUTICALS INC (Issuer) CIK: 0000879993 (see all company filings)

IRS No.: 223103129 | State of Incorp.: NJ | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address
LUNDAHL SCOTT L (Reporting) CIK: 0001205850 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31533 | Film No.: 12699504